• DEEPBLUE Medical takes quick action to implement the donation commitment

    News Mar 20, 2022

    DEEPBLUE Medical takes quick action to implement the donation commitment
    The virus is ruthless, but there is love in the world. At present, in the tense battle of the whole people to fight against the COVID-19 epidemic, DEEPBLUE Medical donated the COVID-19 antigen detection kits, practiced its social responsibility with practical actions, reflected its mission, and helped the epidemic prevention and control work. In order to support Hefei's epidemic prevention and control work, on March 15th and 16th, DEEPBLUE Medical donated  COVID-19 antigen detection kits to the High-tech Zone Emergency Office and Luyang District Emergency Office respectively. The Municipal Red Cross Society donated 2 million copies of the COVID-19 antigen detection kits, explaining the responsibility and responsibility of enterprises with practical actions. In the current epidemic situation, fast words take the lead. In order to send the donated materials to various regions in Hefei as quickly as possible, DEEPBLUE Medical makes it play a role in the prevention and control of the epidemic. As soon as the donation ceremony is over, the deployment of donation matters will be started immediately. Efficiently complete the inventory and docking of donated products, so that each box of the COVID-19 antigen detection kits can exert the greatest value. On the evening of March 19, the staff of the Red Cross Society of Hefei came to the DEEPBLUE Medical Storage Center in Mingzhu Industrial Park to connect the distribution and transportation of reagents on site. The first batch of 430,000 the COVID-19 antigen detection kits were successively sent to Chaohu City, Lujiang County, Yaohai District, Baohe District, Shushan District and Luyang District. At 22 o'clock, the last anti-epidemic material transport vehicle left, and the friends of DEEPBLUE Medical temporarily relaxed their highly tense nerves. In the critical period of epidemic prevention and control, boxes of the COVID-19 antigen detection kits interpret the corporate responsibility and love of DEEPBLUE Medical. DEEPBLUE Medical uses practical actions to transmit positive social energy, and Hefei is more determined to win the epidemic. The battle of prevention and control has injected strong spiritual strength, fighting against the epidemic with everyone and protecting health and tranquility. In this battlefield without gunpowder smoke, DEEPBLUE Medical believes that by working together and united, we will be able to win the battle of epidemic prevention and control as soon as possible!
    View More
  • The second batch of anti-epidemic materials donated by DEEPBLUE Medical has been arranged

    News Mar 24, 2022

    The second batch of anti-epidemic materials donated by DEEPBLUE Medical has been arranged
    On March 22, due to the strong wind and rain, the temperature dropped significantly. After receiving the notice of medical supplies distribution from the Hefei Red Cross Society, the teams from DEEPBLUE Medical expedited packing and labeling the materials at each material demand point. , transport. They braved the wind and rain, and told an extraordinary story in an ordinary position with practical actions...... On the road downstairs in the factory area, the wind and rain can't stop the steps of the DEEPBLUE Medical partners' contribution of love. They are loading trucks in the rain. Everyone dare not stop to ensure that the medical supplies will be delivered in the fastest and shortest time. Shipping is in place. The material transport vehicles are loaded with the COVID-19 antigen detection kits that will be shipped to Hefei counties and districts. These vehicles full of love and warmth will arrive in designated areas around the early morning of March 23. Although it was late at night, the dark blue friends were still busy. In order to prevent the rain on the bottom of the truck from soaking the materials, some quickly found thicker cardboard and spread it on the truck; some quickly put boxes of the COVID-19 antigen detection kits. Packed and transported on pallets; some neatly transported and stacked the donated materials on the pallets in boxes... After loading, the trucks full of materials were covered with rain cloths, bundled and reinforced, arranged in order, and quickly drove to the designated area. 
    View More
  • DEEPBLUE Medical's COVID-19 antigen detection kits are all donated

    News Mar 25, 2022

    DEEPBLUE Medical's COVID-19 antigen detection kits are all donated
    The donation of the third batch of 520,000 and the fourth batch of 547,000 the COVID-19 antigen detection kits by DEEPBLUE Medical came to an end when the last transport vehicle was ready to go on the afternoon of March 24. In just a few days, all the 2 million copies of the COVID-19 antigen test kits that DEEPBLUE Medical promised to donate have been donated, and will be distributed to all counties and districts in Hefei. Since the outbreak of the epidemic, DEEPBLUE Medical has been adhering to the mission and responsibility of the company, and has been paying close attention to the development of the epidemic and social needs. Local prevention and control agencies conduct epidemic prevention and control. This time, DEEPBLUE Medical donated 2 million the COVID-19 antigen detection reagents to the Hefei Red Cross Society, mainly to support Hefei's epidemic prevention and control work and build a strong line of defense. At present, the epidemic situation at home and abroad is still very serious. At this critical moment, we still need to be highly vigilant and not relax at all, whether it is the medical staff on the front line of the hospital, or the party members and volunteers in the community streets, or the workers who produce materials, and the prevention and control workers. Law enforcement police... The epidemic is not over yet, and DEEPBLUE  Medical's support will never stop. DEEPBLUE Medical will, as always, actively undertake social responsibilities, pay close attention to the development of the COVID-19 epidemic, fully support the epidemic prevention and control work, and continue to provide more help for epidemic prevention and control, and always do a good job with the anti-epidemic workers. Get ready to win this battle of epidemic prevention and control without gunpowder smoke together! DEEPBLUE Medical always believes that this "war epidemic" will eventually end, and all good things will come as promised.
    View More
  • Reprint |Two national standards of

    News Jan 04, 2022

    Reprint |Two national standards of "Quality Evaluation Requirements for COVID-19 Antibody Test Kits" were officially released
    Recently, the National Standards Information Service Platform has released a list of 2019 standards issued by the China Institute for Food and Drug Control, the General Hospital of the Chinese People's Liberation Army, the Medical Device Technology Review Center of the State Drug Administration, the Beijing Institute of Medical Device Testing, and the Institute of Pathogen Biology, Chinese Academy of Medical Sciences. , "Quality Evaluation Requirements for Novel Coronavirus IgG Antibody Detection Kits" jointly drafted by 8 units of Zhuhai Livzon Reagent Co., Ltd., Boosaics (Chongqing) Biotechnology Co., Ltd., and Dana (Tianjin) Biotechnology Co., Ltd., Two national standards for "Quality Evaluation Requirements for Novel Coronavirus IgM Antibody Detection Kits". Standard task source The standard task comes from the National Standards Management Committee's "Notice on the issuance of 8 recommended national standards including "Quality Evaluation Requirements for Novel Coronavirus Nucleic Acid Detection Kits" (task number: 202001827-T-464); A large number of investigations were conducted to form a draft, and the Secretariat of the National Standardization Technical Committee for Medical Clinical Testing Laboratories and In Vitro Diagnostic Systems (SAC/TC136) and the Device Evaluation Center of the State Drug Administration were invited to clarify the relevant content. The significance of standard setting Up to now, more than 10 new coronavirus antibody IgM/IgG antibody detection kit products have been approved by my country's drug administration for the detection of antibodies in patients in the new coronavirus pneumonia epidemic. According to incomplete statistics, there are more than 30 A company has issued an EU CE self-conformity declaration. Therefore, related products are not only needed for the prevention and control of the new crown pneumonia epidemic at home and abroad, but also involve greater foreign economic and trade and the country's international responsibilities. Up to now, there is no standard for new coronavirus antibody detection products at home and abroad. The two national standards released this time are applicable to the production and quality evaluation of detection kits for the detection of 2019-nCoV antibodies in serum, plasma and whole blood samples. The evaluation requirements, test methods, packaging and transportation are specified in detail. By implementing the above two standards, the existing domestic new coronavirus detection products can be fully regulated, which will help to comprehensively evaluate the quality of the new coronavirus detection products to better meet the needs of clinical diagnosis. The standard will be officially implemented on March 1, 2022.
    View More
  • News Oct 31, 2021

    "DEEPBLUE" has been successfully approved and protected in Austria
    On October 28, 2021, the "DEEPBLUE" trademark of Anhui Deepblue Medical was successfully approved and protected by Austria. This is another milestone in the development history of Anhui Deepblue Medical, which marks that the Deepblue brand's strategy of going global has achieved remarkable results. We all know that trademarks are important intellectual property rights and high value-added intangible assets of enterprises, and trademarks are geographically restricted. A trademark registered in China can only mean that the trademark has exclusive rights in China. When the trademarked product is exported overseas , if there is no trademark "protective clothing" of the importing country, then the product of the trademark is not protected by the laws of that country. For Anhui Deepblue Medical, which has a long-term plan, the registration of international trademarks is a necessary strategic measure. The "DEEPBLUE" series products of Anhui Deepblue Medical have a high reputation in domestic and foreign markets in terms of quality and reputation. This time, the successful approval of Austrian protection not only improves the core competitiveness of the "DEEPBLUE" brand, but also lays the foundation for the higher-level strategic layout of Deepblue Medical.
    View More
  • Leaders of Zhang Lei from Anhui Provincial Food and Drug Administration visited Deepblue Medical for research and guidance

    News Nov 05, 2021

    Leaders of Zhang Lei from Anhui Provincial Food and Drug Administration visited Deepblue Medical for research and guidance
    On the afternoon of November 2, 2021, Deputy Director Zhang Lei of Anhui Provincial Drug Administration (hereinafter referred to as "Provincial Drug Administration") and the leaders of the licensing registration office visited Anhui Deepblue Medical for research and guidance. Anhui Deepblue Medical Technology Co., Ltd. (hereinafter (referred to as "Deepblue Medical") Chairman Zhang Chao and General Manager Chen Fengling warmly received and accompanied the whole process, and the principals of various functional departments participated in the meeting. During the research activities, the leaders of the Provincial Food and Drug Administration made an in-depth on-site inspection, and successively visited the Deepblue medical research and development center, quality inspection center, production workshop, warehouse, etc. Zhang Chao, the chairman of the company, introduced the development history, industrial chain, domestic and foreign development of deepblue medical The layout and product development, etc., and made a report on the company's future development plan. Director Zhang and his party fully affirmed the development of Deepblue Medical for more than ten years. At the symposium, Deputy Director Zhang analyzed and introduced the draft of Anhui Province's second-class medical device priority approval method, emphasizing that the provincial bureau takes the enterprise service purpose and implements the State Council's policy of delegating, regulating and serving; for common problems in enterprise registration and quality management issues to communicate. Deputy Director Zhang and Director Chen Yongmei and Deputy Director Xiong Yongheng of the Licensing Registration Office expressed that the Provincial Food and Drug Administration is willing to be a bridge between enterprises and the State Food and Drug Administration and other units to help enterprises solve related difficulties in the development process. Regarding the issues of concern in the research and development of enterprises, he said that he would consider establishing an early intervention mechanism in the registration stage to avoid detours in the registration application, and further optimize the medical device review process to speed up the review progress. Finally, the leaders of the Provincial Food and Drug Administration hope that Deepblue Medical will continue to innovate in research and development, and according to the market transition from "passive health management" to "active health management", strive to produce more products that meet market demand, and truly give full play to POCT products. The role of health warning. General Manager Chen Fengling said that he thanked the leaders of the provincial bureau for their concern and spared no time to go to the enterprise to provide door-to-door service. Deepblue Medical will give full play to its talents and technical advantages, innovate ideas, fully participate in the construction of the whole industry chain of in vitro diagn...
    View More
  • Deepblue Medical International Trademark

    News Nov 11, 2021

    Deepblue Medical International Trademark "DEEPBLUE" Approved and Protected by Bulgaria
    On November 3, the good news of Deep Blue Medical - "DEEPBLUE" trademark was approved and protected by Bulgaria. This is another powerful tool for property rights protection obtained by "DEEPBLUE" after the recent approval of protection by Spain and Austria, and it is also another milestone towards the international market. With my country's entry into the WTO and the acceleration of Chinese enterprises' "going global" pace, the issue of international trademark protection has gradually emerged. Trademarks are an important part of an enterprise's intangible assets and comprehensive competitiveness. Deepblue Medical is well aware of the importance of trademark registration, so in the development strategy of Deepblue Medical, trademark protection occupies an important position. The implementation of the trademark strategy of Deepblue Medical is not only the internal driving force for the continuous expansion of scale, but also a strong guarantee for Deepblue Medical to enter the international market. As early as 2010, the company started to carry out trademark planning when it was first established. At present, it has 15 domestic trademarks. In 2020, the first batch of international trademark registrations will be registered through the Madrid system. In the international protection of the trademark of Deepblue Medical "DEEPBLUE", in addition to applying for trademark registration country by country, the Madrid trademark system is also an important way and means for Deepblue Medical to use it. With the approval and protection of many overseas countries, the global registration of the main brand trademark of "DEEPBLUE" has basically been realized, which has cleared the intellectual property obstacles for the future expansion of DeepBlue Medical's overseas business. Up to now, the company has carried out trademark registration work in more than 50 countries and regions around the world through the Madrid system and other organizations, basically covering the main overseas markets and potential markets of "DEEPBLUE".
    View More
  • Deepblue Medical's

    News Nov 26, 2021

    Deepblue Medical's "DEEPBLUE" international trademark has been protected by many countries
    On November 23, the good news came from Deepblue Medical that the "DEEPBLUE" international trademark was successfully approved and protected by France, Australia and the Czech Republic. The development of soft power will further promote the development of deep blue medical in foreign markets, create a deep blue brand, and improve the comprehensive competitiveness of Deepblue medical. In the international protection of the "DEEPBLUE" trademark, in addition to applying for trademark registration country by country, the Madrid international trademark registration system is an important way and means for brands to borrow. The Madrid System is a solution for global trademark registration and management. Through a centralized system, trademarks can not only apply for protection in up to 120 countries, but also change, renew or expand global trademarks. Up to now, the "DEEPBLUE" brand trademark has obtained trademark exclusive rights in 20 countries including Italy, the Netherlands, Germany, Spain, Austria, and Bulgaria, and has continuously extended the exclusive rights to other member states of the Madrid System. In the next step, Deepblue Medical will continue to strengthen the company's trademark reserve and management level based on the company's advantages, apply for trademark registration in advance according to business development and corporate planning, and prepare for the listing of Deepblue products, corporate brand building, and image enhancement. The market offers more opportunities.
    View More
  • The trademark

    News Dec 16, 2021

    The trademark "DEEPBLUE" was successfully registered and approved in Slovakia
    Trademarks are an important part of an enterprise's intangible assets and comprehensive competitiveness. At present, Deepblue Medical's Chinese, English and graphic trademarks have all applied for registration protection, effectively protecting the company's intangible assets and legitimate rights and interests. Over the years, the company has continued to explore the international market, and the number of countries and regions for product export has continued to increase. In order to further protect the company’s rights and interests in the international market, the company has continued to expand its brand influence and market share. In 2020, Deepblue Medical carried out trademark protection in various countries through the Madrid trademark system, and successively received approval and protection. On December 15, DEEPBLUE obtained the approval protection notice from the Slovak State. The successful acquisition of Slovakia’s approval and protection this time is an important step and result of Deepblue Medical’s establishment of a global brand. It is also a strong guarantee for the protection of the exclusive rights of Deepblue Medical’s overseas trademarks. It is a milestone for Deepblue’s future development and is a brand competition for Deepblue. It has laid a solid foundation for achieving innovation-driven, boosting the development of foreign markets, creating high-quality brands, and achieving higher-level development.
    View More
1 2 3

A total of 3 pages

SEND A MESSAGE
If you have questions or suggestions,please leave us a message,we will reply you as soon as we can!
top
Leave A Message
Leave A Message
If you have questions or suggestions,please leave us a message,we will reply you as soon as we can!

Home

Product